Primemd Inc.
PRMD · OTC
12/31/2021 | 3/31/2008 | 3/31/2007 | 3/31/2006 | |
|---|---|---|---|---|
| Market Cap | $5 | $0 | $1 | $1 |
| - Cash | $3 | $0 | $1 | $1 |
| + Debt | $7 | $0 | $0 | $0 |
| Enterprise Value | $9 | -$0 | $0 | -$0 |
| Revenue | $11 | $0 | $0 | $0 |
| % Growth | 15,388.8% | 38% | -6.6% | – |
| Gross Profit | $11 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $3 | -$0 | -$0 | -$0 |
| % Margin | 32.6% | -153% | -432.3% | -300.1% |
| Net Income | $3 | -$0 | $0 | -$0 |
| % Margin | 29.9% | -149.1% | 396.2% | -295.4% |
| EPS Diluted | 0.17 | -0.033 | 0.063 | -0.051 |
| % Growth | 616.7% | -151.9% | 225.3% | – |
| Operating Cash Flow | $3 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$1 | $0 | $0 | $0 |
| Free Cash Flow | $2 | -$0 | -$0 | -$0 |